down arrow

Hayat Pharmaceutical Industries Co. Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JO4121011012
JOD
3.25
0.05 (1.56%)

Mar 24

AMM

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Dar Al Dawa Development & Investment Co. Ltd.
Philadelphia Pharmaceuticals Co.
Hayat Pharmaceutical Industries Co. Ltd.

Why is Hayat Pharmaceutical Industries Co. Ltd. ?

1
Flat results in Dec 25
  • DIVIDEND PAYOUT RATIO(Y) Lowest at 0%
  • ROCE(HY) Lowest at 0%
  • RAW MATERIAL COST(Y) Grown by 6.98% (YoY)
2
With ROE of 10.18%, it has a fair valuation with a 0.00 Price to Book Value
  • Over the past year, while the stock has generated a return of 9.43%, its profits have risen by 2%
3
Underperformed the market in the last 1 year
  • The stock has generated a return of 9.43% in the last 1 year, much lower than market (Jordan General Index) returns of 41.27%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hayat Pharmaceutical Industries Co. Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Hayat Pharmaceutical Industries Co. Ltd.
9.43%
1.48
22.11%
Jordan General Index
41.27%
4.23
9.76%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.63%
EBIT Growth (5y)
3.45%
EBIT to Interest (avg)
3.30
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
2.16
Tax Ratio
12.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.28%
ROE (avg)
10.21%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-1.42
EV to EBITDA
-1.03
EV to Capital Employed
-0.18
EV to Sales
-0.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
10.18%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
OPERATING PROFIT(Q)

Highest at JOD 2.94 MM

OPERATING PROFIT MARGIN(Q)

Highest at 56.47 %

-10What is not working for the Company
DIVIDEND PAYOUT RATIO(Y)

Lowest at 0%

ROCE(HY)

Lowest at 0%

RAW MATERIAL COST(Y)

Grown by 6.98% (YoY

CASH AND EQV(HY)

Lowest at JOD 9.02 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 0 times

DIVIDEND PER SHARE(HY)

Lowest at JOD 0

EPS(Q)

Lowest at JOD 0

Here's what is working for Hayat Pharmaceutical Industries Co. Ltd.

Operating Profit
Highest at JOD 2.94 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (JOD MM)

Operating Profit Margin
Highest at 56.47 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Here's what is not working for Hayat Pharmaceutical Industries Co. Ltd.

Dividend Payout Ratio
Lowest at 0% and Fallen
In each year in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)

EPS
Lowest at JOD 0
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (JOD)

Cash and Eqv
Lowest at JOD 9.02 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Dividend per share
Lowest at JOD 0
in the last five years
MOJO Watch
Company is distributing lower dividend than previous years

DPS (JOD)

Raw Material Cost
Grown by 6.98% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."